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Addiction to drugs and alcohol is a dynamic and multi-faceted
disease process in humans, with devastating health and financial
consequences for the individual and society at large. The recently
released fifth edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-V) combined the previously separate
abuse and dependence classifications for licit and illicit drugs of
abuse into a single syndrome called substance use disorder (SUD).
This new definition includes diagnostic criteria that are largely
overlapping with previous criteria (DSM-IV), and new diagnos-
tic thresholds wherein physicians are charged with classifying the
severity of an individual’s SUD based on the number of criteria
met. More specifically, mild SUD requires that two to three symp-
toms be met, moderate SUD requires that four to five symptoms be
met, and severe SUD requires that six or more symptoms be met.
One notable addition to diagnostic criteria is craving, which can
be defined broadly as a strong desire or urge to use drug/alcohol.
Different classes of abused drugs can have different biological con-
sequences and different co-morbidity risks, but SUDs are defined
and diagnosed according to a single set of behavioral symptoms
that are common to abuse of all drugs. These behavioral symp-
toms include compulsive drug use, loss of control in limiting drug
intake, the emergence of a negative emotional state in the absence
of the drug, and increased vulnerability to relapse triggered by
stress or cues previously associated with drug availability. Each of
these symptoms can be modeled to various degrees in animals, and
animal models are particularly useful for exploring the underlying
neurobiology of SUD and for identifying promising new targets
for treatments aimed at curbing excessive drug and alcohol use in
humans.
The main purpose of this Research Topic is to consolidate
review and empirical articles by leaders in the addiction field that
collectively explore the contribution of brain reward and stress
systems in addiction. The transition to severe SUD is defined
by neuroadaptations in brain circuits that, in the absence of
drugs, are responsible for mediating behavioral and physiological
processes that include motivation, positive and negative emotional
states, nociception, and feeding. Chronic drug exposure during
this transition promotes (1) within-system changes in neural cir-
cuits that contribute to the acute rewarding effects of the drug
and (2) recruitment of both hypothalamic (neuroendocrine) and
extra-hypothalamic brain stress systems.
Various biological and behavioral processes contribute to the
propensity of an individual to use and abuse drugs and alcohol.
For example, links are emerging between specific genetic pro-
files and diagnoses of SUDs. Furthermore, drug and alcohol
abuse are highly co-morbid with other psychiatric conditions
(e.g., anxiety disorders, major depressive disorder, schizophre-
nia, and personality disorders) that may precede or follow the
development of drug use problems. Across different drugs of
abuse, there are overlapping and dissociable aspects of the behav-
ioral and neurobiological changes that define the transition to
dependence. Even within a single drug of abuse, different peo-
ple abuse drugs for various reasons; within a single individ-
ual, the reasons for drug abuse may change across the lifespan
and the course of the disorder. The picture is further compli-
cated by the fact that humans often abuse more than one drug
concurrently.
This Research Topic begins with a review by Dr. George Koob,
Ph.D., newly appointed Director of the National Institute on
Alcohol Abuse and Alcoholism (NIAAA), that describes addic-
tion as a disorder mediated by pathophysiological reductions
in brain reward function and concurrent recruitment of brain
stress circuits (1). Several of the articles that follow build on the
idea that recruitment of brain stress systems [e.g., corticotropin-
releasing factor (CRF) and glucocorticoids] is critical for pro-
moting excessive drug and alcohol use. The remainder of this
Research Topic is a collection of empirical and review articles
that describe work aimed at unraveling the neurobiology of
addiction to various drugs of abuse, and that ties this neurobi-
ology with various current “hot topics” in the addiction research
field (2–14).
The articles in this Research Topic address various points of
current emphasis in the addiction research field. One such area
is the idea of individual differences: it is gradually being accepted
that addicts across and within drugs of abuse are not all the same,
that individuals may arrive at the same phenotypic or diagnostic
endpoint by different life paths and precipitating factors, that indi-
viduals exhibit different sets of co-morbidities (e.g., addiction and
pain), and that therapeutic approaches and clinical trials may be
more effective if tailored to subpopulations of addicts (i.e., phar-
macogenetics). Also addressed in this set of articles is the notion
that individual neurochemical systems may be critical for medi-
ating not only abuse of more than one drug, but for mediating
co-abuse of more than one drug in a single individual (e.g., the
high rates of co-morbid smoking in individuals with alcohol use
disorder). Another area of major social concern that is currently
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receiving much attention in the addiction research field is the drive
to understand the long-term effects of adolescent drug and alcohol
exposure on brain and behavior. It is generally accepted that early
initiation of drug and alcohol use increases the risk for develop-
ment of SUD and other psychiatric conditions later in life, and
this may be due to the fact that the adolescent brain, because it
is still developing, is particularly vulnerable to the effects of these
substances.
Pre-clinical research utilizes a variety of animal models and
rapidly advancing technological approaches to explore the under-
lying neurobiology of drug addiction. Several articles in this
Research Topic describe commonly used genetic models (e.g.,
selective breeding animals for high alcohol preference) and more
recently developed exposure models (e.g., nicotine vapor as a
model for e-cigarettes and second-hand smoke) of addiction.
These models can be combined with new technologies (e.g.,
optogenetics and chemogenetics) to examine the neurobiol-
ogy of addiction in increasingly sophisticated ways, for exam-
ple, the approach of isolating single brain regions is quickly
being replaced by circuitry approaches, and intra-cranial deliv-
ery of drug solutions with “dirty” receptor binding and dif-
fusion profiles are being replaced by highly controllable opti-
cal stimulation and designer drug techniques. Collectively, the
articles presented here provide a snapshot of the current the-
oretical and experimental landscape in the addiction research
field.
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